PeptideDB

ZYZ-803

CAS No.: 2088043-51-8

ZYZ-803 is a slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description ZYZ-803 is a slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure.
Synonyms ZYZ 803
molecular weight 433.48
Molecular formula C20H23N3O6S
CAS 2088043-51-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Wu D, Hu Q, Xiong Y, Zhu D, Mao Y, Zhu YZ. Novel H(2)S-NO hybrid molecule (ZYZ-803) promoted synergistic effects against heart failure. Redox Biol. 2018 May;15:243-252. doi: 10.1016/j.redox.2017.11.020. Epub 2017 Dec 14. PubMed PMID: 29288927; PubMed Central PMCID: PMC5975222. 2. Hu Q, Wu D, Ma F, Yang S, Tan B, Xin H, Gu X, Chen X, Chen S, Mao Y, Zhu YZ. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule. Antioxid Redox Signal. 2016 Sep 10;25(8):498-514. doi: 10.1089/ars.2015.6607. Epub 2016 Jun 29. PubMed PMID: 27174595. 3. Wu D, Hu Q, Ma F, Zhu YZ. Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway. Oxid Med Cell Longev. 2016;2016:7075682. doi: 10.1155/2016/7075682. Epub 2015 Nov 9. PubMed PMID: 26635911; PubMed Central PMCID: PMC4655279.